| Pharmaceutical active ingredients: |
| Metronidazole |
| Available forms, composition and doses of Cont: |
| N / A |
| Cont medical category: |
| Human:AntiamoebicsAntibioticsAntiprotozoal agentsAntiseptic skin cleansersLocal anti-infectivesPreparations for vaginal conditionsTopical chemotherapeutics used in the treatment of dermatological diseases |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| A01AB17 - MetronidazoleD06BX01 - MetronidazoleG01AF01 - MetronidazoleJ01XD01 - MetronidazoleP01AB01 - Metronidazole |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Unidentified Pharmaceutical Company |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Consist | Trifloxystrobin | Unidentified Pharmaceutical Company |
| Consol Violet | Methyl Violet | Unidentified Pharmaceutical Company |
| Consolan | Nabumetone | Unidentified Pharmaceutical Company |
| Constan | Alprazolam | Unidentified Pharmaceutical Company |
| Constimol | Pemoline | Unidentified Pharmaceutical Company |
| Contalyl | Methixene | Unidentified Pharmaceutical Company |
| Conteben | Thioacetazone | Unidentified Pharmaceutical Company |
| Contergan | Thalidomide | Unidentified Pharmaceutical Company |
| Continal | Pentobarbital | Unidentified Pharmaceutical Company |
| Contol | Chlordiazepoxide | Unidentified Pharmaceutical Company |